These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14431691)

  • 1. [Factors in expenditures for pharmaceuticals].
    PEQUIGNOT H; ROSCH G; VESSEREAU A
    Sem Med Prof Med Soc; 1959 Aug; 35():783-4. PubMed ID: 14431691
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-32. PubMed ID: 25771553
    [No Abstract]   [Full Text] [Related]  

  • 3. [INVESTIGATIONS ON EXPENDITURES FOR DRUGS. SOME RESULTS OF RESEARCH IN THE DISTRICT INSTITUTE OF NATIONAL HEALTH IN RYCHNOV NAD KN E ZNOU IN MARCH AND APRIL 1963].
    OMELCUK A; STACH J
    Cesk Zdrav; 1964 Aug; 12():370-8. PubMed ID: 14194289
    [No Abstract]   [Full Text] [Related]  

  • 4. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
    Davidova J; Praznovcova L; Lundborg CS
    Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [STUDIES ON EXPENDITURES FOR DRUGS. SOME RESULTS OF RESEARCH FROM THE REGIONAL HEALTH OFFICE IN RYCHNOV NAD KNEZNOU IN MARCH AND APRIL 1963].
    OMELCUK A; STACH J
    Pharm Prax; 1965; 3():55-9. PubMed ID: 14309176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of economic evaluation in the listing and pricing of pharmaceuticals].
    Lee TJ
    J Prev Med Public Health; 2008 Mar; 41(2):69-73. PubMed ID: 18385545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-31. PubMed ID: 25771554
    [No Abstract]   [Full Text] [Related]  

  • 8. Health reform costly to hospital pharmacies.
    Wilson CN
    Hosp Pharm; 1993 Jun; 28(6):554, 556, 559-60. PubMed ID: 10126456
    [No Abstract]   [Full Text] [Related]  

  • 9. Mega-mergers in the pharmaceutical industry. In whose interests?
    Po AL
    Pharmacoeconomics; 1998 Oct; 14(4):349-55. PubMed ID: 10344903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can drug consumption in general be reduced and can drug costs for insurance carriers be reduced?].
    TOELKE S
    Pharm Prax; 1959; 10():149-53. PubMed ID: 13838637
    [No Abstract]   [Full Text] [Related]  

  • 11. Insurance against drug costs--a progress report.
    WILKINSON WA
    Am J Public Health Nations Health; 1960 May; 50(5):670-4. PubMed ID: 13844765
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
    [No Abstract]   [Full Text] [Related]  

  • 13. A new paradox: drugs too cheap to stay available.
    Allerberger F; Dierich MP
    Bull World Health Organ; 2000; 78(1):146. PubMed ID: 10686749
    [No Abstract]   [Full Text] [Related]  

  • 14. Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes.
    Ioannides-Demos LL; Ibrahim JE; McNeil JJ
    Pharmacoeconomics; 2002; 20(9):577-91. PubMed ID: 12141886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative factors underlying the successful investment in new ophthalmic pharmaceutical products in the United States.
    Stewart WC; Chaney PG; Stewart JA; Kruft B; Nelson LA
    Acta Ophthalmol; 2013 Sep; 91(6):e496-7. PubMed ID: 23834660
    [No Abstract]   [Full Text] [Related]  

  • 16. Express Scripts? Really?
    Tempero M
    J Natl Compr Canc Netw; 2015 Jul; 13(7):827. PubMed ID: 26150575
    [No Abstract]   [Full Text] [Related]  

  • 17. Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007-18.
    Divino V; DeKoven M; Kleinrock M; Wade RL; Kaura S
    Health Aff (Millwood); 2016 Sep; 35(9):1588-94. PubMed ID: 27605637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines for economic evaluation of pharmaceuticals in Korea].
    Bae EY
    J Prev Med Public Health; 2008 Mar; 41(2):80-3. PubMed ID: 18385547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: business practices. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448
    [No Abstract]   [Full Text] [Related]  

  • 20. Grounding Value-Based Drug Pricing in Population Health.
    Kaltenboeck A; Calsyn M; Frederix GWJ; Lowenthal J; Mitchell D; Rector B; Sarpatwari A
    Clin Pharmacol Ther; 2020 Jun; 107(6):1290-1292. PubMed ID: 31953850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.